APPEAL: a toolkit for attracting people who inject drugs with hepatitis C to healthcare systems

被引:0
|
作者
Baptista-Leite, Ricardo [1 ,2 ]
Lopes, Henrique [1 ]
Franco, Diogo [1 ]
Clemens, Timo [2 ]
Brand, Helmut [2 ]
机构
[1] Univ Nova Lisboa, NOVA Ctr Global Hlth, NOVA IMS, Lisbon, Portugal
[2] Maastricht Univ, CAPHRI, Dept Int Hlth, Fac Hlth Med & Life Sci, Maastricht, Netherlands
来源
JOURNAL OF PUBLIC HEALTH-HEIDELBERG | 2024年
基金
英国科研创新办公室;
关键词
Public health; People who inject drugs (PWID); Hepatitis C; Vulnerable groups; Care cascade; Service quality improvement; DISEASE; VIRUS; RISK; HIV; HCV;
D O I
10.1007/s10389-024-02276-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim The "APPEAL" toolkit was developed to address the challenges in diagnosing people who inject drugs (PWID) with hepatitis C (HCV) and engaging them with healthcare systems. It introduces an ecosystemic approach based on health and well-being literacy across awareness, prevention and diagnosis dimensions of the hepatitis C's care cascade (CC) for PWID.Subject and methods The framework incorporated a scoping review and thematic analysis of 54 studies, alongside contributions from 57 hepatitis C key opinion leaders across seven countries. The toolkit is structured around five main axes: problems, solutions, outputs, outcomes and feedback process, employing a holistic perspective that considers economic, legal and social contexts. Eighteen policy prescriptions (PP) are proposed and supported by selective references to ensure relevance and applicability.Results The APPEAL toolkit facilitates a strategic workflow for policymakers, health authorities and patient advocacy organizations, guiding them through action flowcharts to evaluate and enhance their interventions within the hepatitis C's CC for PWID. Notably, its implementation demonstrated potential in identifying and attracting PWID to hepatitis C treatment pathways, contributing to increased diagnostics, education on risk behaviours and raising overall disease awareness. The toolkit's intelligent cycle system supports accountability, enabling continuous data-driven improvement and innovation in addressing hepatitis C.Conclusion The APPEAL toolkit was developed to attract PWID living with HCV to healthcare systems in a proactive manner. By managing information and fostering education on HCV, it aims to amplify awareness, prevention and diagnosis. The toolkit's design and functionality underscore the importance of continuous quality improvement and the potential for its use in internal or external quality audits of healthcare services related to hepatitis C.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals
    Mah, Allison
    Hull, Mark W.
    DeBeck, Kora
    Milloy, Michael John
    Dobrer, Sabina
    Nosova, Ekaterina
    Wood, Evan
    Kerr, Thomas
    Hayashi, Kanna
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 : 137 - 143
  • [32] Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London
    Aisyah, D. N.
    Shallcross, L.
    Hayward, A.
    Aldridge, R. W.
    Hemming, S.
    Yates, S.
    Ferenando, G.
    Possas, L.
    Garber, E.
    Watson, J. M.
    Geretti, A. M.
    McHugh, T. D.
    Lipman, M.
    Story, A.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (11) : 1260 - 1269
  • [33] Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine
    Iakunchykova, Olena
    Meteliuk, Anna
    Zelenev, Alexei
    Mazhnaya, Alyona
    Tracy, Melissa
    Altice, Frederick L.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 57 : 11 - 17
  • [34] Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030
    Meijerink, Hinta
    White, Richard A.
    Lovlie, Astrid
    de Blasio, Birgitte Freiesleben
    Dalgard, Olav
    Amundsen, Ellen J.
    Melum, Espen
    Klovstad, Hilde
    BMC INFECTIOUS DISEASES, 2017, 17
  • [35] Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California
    Ozga, Jenny E.
    Syvertsen, Jennifer L.
    Pollini, Robin A.
    JOURNAL OF VIRAL HEPATITIS, 2022, 29 (07) : 518 - 528
  • [36] Hepatitis C Transmission and Treatment in Contact Networks of People Who Inject Drugs
    Rolls, David A.
    Sacks-Davis, Rachel
    Jenkinson, Rebecca
    McBryde, Emma
    Pattison, Philippa
    Robins, Garry
    Hellard, Margaret
    PLOS ONE, 2013, 8 (11):
  • [37] Human rights and access to hepatitis C treatment for people who inject drugs
    Wolfe, D.
    Luhmann, N.
    Harris, M.
    Momenghalibaf, A.
    Albers, E.
    Byrne, J.
    Swan, T.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (11) : 1072 - 1080
  • [38] Hepatitis C and the limits of medicalisation and biological citizenship for people who inject drugs
    Fraser, Suzanne
    ADDICTION RESEARCH & THEORY, 2010, 18 (05) : 544 - 556
  • [39] Dynamic modeling of hepatitis C transmission among people who inject drugs
    Stocks, Theresa
    Martin, Leah J.
    Kuhlmann-Berenzon, Sharon
    Britton, Tom
    EPIDEMICS, 2020, 30
  • [40] HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment
    Walsh, Nick
    Maher, Lisa
    CURRENT OPINION IN HIV AND AIDS, 2012, 7 (04) : 339 - 344